Heaps of a copycat erectile dysfunction med are flying off U.S. shelves, though not for the reason manufacturer Sun Pharmaceutical Industries might hope.
India's Sun Pharma is recalling more than 100,000 bottles in the U.S. of its generic tadalafil tablet for erectile dysfunction (ED), because the "incorrect grade" of an inactive ingredient was added during production, The Economic Times reports, citing the U.S. FDA's latest enforcement report.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,